Brown DM - Search Results

1

CLINICALLY RELEVANT POSTERIOR VITREOUS DETACHMENT STAGING USING CIRCUMPAPILLARY AND MACULAR VOLUME OPTICAL COHERENCE TOMOGRAPHY.

Brown DM, Laswell SM, Rahman EZ, Fan KC, Shah A, Patel SB, Wykoff CC. Brown DM, et al. Retina. 2024 Aug 1;44(8):1441-1448. doi: 10.1097/IAE.0000000000004115. Retina. 2024. PMID: 39047131 Free PMC article.

2

Long-term stability of circumferential silicone sponge scleral buckling exoplants.

Brown DM, Beardsley RM, Fish RH, Wong TP, Kim RY. Brown DM, et al. Retina. 2006 Jul-Aug;26(6):645-9. doi: 10.1097/01.iae.0000236473.63819.f4. Retina. 2006. PMID: 16829806

3

Selected clinical comparisons of spectral domain and time domain optical coherence tomography.

Luviano DM, Benz MS, Kim RY, Fish RH, Wong TP, Kegley EN, Brown DM. Luviano DM, et al. Among authors: brown dm. Ophthalmic Surg Lasers Imaging. 2009 May-Jun;40(3):325-8. doi: 10.3928/15428877-20090430-20. Ophthalmic Surg Lasers Imaging. 2009. PMID: 19485303

4

Endophthalmitis after intravitreal injection: the importance of viridans streptococci.

Chen E, Lin MY, Cox J, Brown DM. Chen E, et al. Among authors: brown dm. Retina. 2011 Sep;31(8):1525-33. doi: 10.1097/IAE.0b013e318221594a. Retina. 2011. PMID: 21878800

5

Anatomical measures as predictors of visual outcomes in ranibizumab-treated eyes with neovascular age-related macular degeneration.

Brown DM, Tuomi L, Shapiro H; Pier Study Group. Brown DM, et al. Retina. 2013 Jan;33(1):23-34. doi: 10.1097/IAE.0b013e318263cedf. Retina. 2013. PMID: 23073338 Clinical Trial.

6

SAVE (Super-dose anti-VEGF) trial: 2.0 mg ranibizumab for recalcitrant neovascular age-related macular degeneration: 1-year results.

Wykoff CC, Brown DM, Chen E, Major JC, Croft DE, Mariani A, Wong TP; SAVE Study Group. Wykoff CC, et al. Among authors: brown dm. Ophthalmic Surg Lasers Imaging Retina. 2013 Mar-Apr;44(2):121-6. doi: 10.3928/23258160-20130313-04. Ophthalmic Surg Lasers Imaging Retina. 2013. PMID: 23510037 Clinical Trial.

7

Comparison of spectral-domain and time-domain optical coherence tomography in the detection of neovascular age-related macular degeneration activity.

Major JC Jr, Wykoff CC, Mariani AF, Chen E, Croft DE, Brown DM. Major JC Jr, et al. Among authors: brown dm. Retina. 2014 Jan;34(1):48-54. doi: 10.1097/IAE.0b013e3182965743. Retina. 2014. PMID: 23764967 Clinical Trial.

8

Two Year SAVE Outcomes: 2.0 mg ranibizumab for recalcitrant neovascular AMD.

Wykoff CC, Brown DM, Croft DE, Wong TP. Wykoff CC, et al. Among authors: brown dm. Ophthalmology. 2013 Sep;120(9):1945-6.e1. doi: 10.1016/j.ophtha.2013.06.030. Ophthalmology. 2013. PMID: 24001533 Clinical Trial. No abstract available.

9

Outcomes of macular hole surgeries for macular telangiectasia type 2.

Karth PA, Raja SC, Brown DM, Kim JE. Karth PA, et al. Among authors: brown dm. Retina. 2014 May;34(5):907-15. doi: 10.1097/IAE.0000000000000009. Retina. 2014. PMID: 24270919

10

Aflibercept treatment for patients with exudative age-related macular degeneration who were incomplete responders to multiple ranibizumab injections (TURF trial).

Wykoff CC, Brown DM, Maldonado ME, Croft DE. Wykoff CC, et al. Among authors: brown dm. Br J Ophthalmol. 2014 Jul;98(7):951-5. doi: 10.1136/bjophthalmol-2013-304736. Epub 2014 Feb 11. Br J Ophthalmol. 2014. PMID: 24518078 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,075 results

Search Page

Filters